A Study of HER2+ Breast Cancer Patients With Active Brain Metastases Treated With Afatinib & T-DM1 vs. T-DM1 Alone
Conditions: HER2-positive Breast Cancer; Brain Metastases Interventions: Drug: Afatinib; Drug: T-DM1 Sponsor: xuexin he Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain | Brain Cancers | Breast Cancer | Cancer | Cancer & Oncology | HER2 | Neurology | Research | Study